Imbruvica (ibrutinib) is a targeted therapy used to treat chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), Waldenström’s macroglobulinemia (WM), and chronic graft versus host disease (cGVHD) in certain patients. Imbruvica helps slow cancer progression in CLL, SLL, and WM, and slow disease progression in cGVHD.  imbruvica price